Research On Development Strategy Of New Drug R&d Technology Platform In Our Country

As an important socialized form of production, platform has been used in many domains and played a more and more crucial role in the fields of society, economy, science and technology. New drug R&D technology is a kind of innovative activities which tightly combines with many factors such as technology, knowledge, capital, equipment, talents and so on. The technology platform has already become major carriers and basic tools for the modern pharmaceutical R&D. The innovation abilities of the pharmaceutical industry in our country are relatively weak, which could not satisfy the increasingly demands for health in land, facing the threatening from the foreign pharmaceutical companies. Currently, the government, pharmaceutical industries, scientific research institutes and some universities have already reached a consensus that the innovative system of our medical science and technology should be established quickly, all kinds of innovative factors should be encouraged and lead to the enterprises so as to promote the enterprises to become the innovation subject, and to realize the great-leap-forward development of the innovative ability of medical science and technology in our country.In the research, the new drug R&D technology platform was chosen as the entry point and the platform as the research subject. The related stake-holders in the new drug R&D technology, the R&D pattern, development status, problems of existence were initially analyzed and explored for the purpose of providing some beneficial suggestions and references to promote the establishment and improvement of the new drug R&D technology platform system as soon as possible. The main subject such as: ordinary economics phenomenon during the new drug R&D; the basic features and the causes of creation of the platform, technology platform and the new drug R&D technology platform; the interior factors, exterior factors, the influential factors of the new drug R&D technology platform and their functions; the establishment and development experiences of the new drug R&D technology platform in foreign countries; the current situation and the problems of the pharmaceutical R&D technology platform in land; the development strategy of pharmaceutical R&D technology platform of our country, were investigated by the methods of economics analysis, expert consultation, systematic analysis, case study and comparative study, etc.The major conclusions are as follows: the upstream of the new drug R&D show obvious features of public services whereas the downstream show great commercial features. The chain of new drug R&D involves many stakeholders and which has a long technology chain, and needs the cooperation of factors from different levels such as technology, economy and administration under the lead of the government. The new drug R&D technology platform is a comparatively centralized, organic and innovative method which combines technology, talents and equipment, etc., in certain time and space, which could reduces the innovative cost and promotes R&D efficiency significantly. According to the attribute of the products, the new drug R&D technology platform could be categorized into semi-public products platform and personal products platform, which should be established with the organic interface of the government and some privately-owned enterprises following the regulars of market and technology development on the construction and administration.. Property right plays a vital role in the allocation efficiency and utilizing efficiency of the resources. Therefore, optimizing the property right structure might be one of the applicable ways to resolve the problems of the low utilizing efficiency of pharmaceutical R&D technology platform and weak consciousness of the share service In order to speed up the construction and development of the new drug R&D technology platform of our country and promote the innovative ability of the new drug R&D, it is necessary to combine the whole state support system and the market mechanism. The government should strengthen the top design and macro-control, scientifically deploy the pharmaceutical R&D technology platform in accordance with the inner features of the new drug R&D as well as the situation of the country, with the reinforcement of policy guide and administration supervision. The government should build a sound environment for the innovation of medical science and technology, give full play to the market's allocation function, encourage and guide the enterprises to become the main forces of building the new drug R&D technology platform, gradually shift the focus and investment to the construction and development of some platforms which are fundamental, beneficial, strategic and research-oriented. In addition, the government should reduce the administration cost, define the emphasis, and establish a supervision and administration mechanism concentrating on the performance evaluation, which could promote the administration efficiency and the outcomes of the technology platform.